EVOGENE LTD. Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method
EVOGENE LTD. (EVGN) reported Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method of $0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod · last filed 2026-03-26
| Period end | Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method 6 month | Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method 12 month |
|---|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-03-26 | |
| 2024-12-31 | $0.00 20-F · filed 2026-03-26 | |
| 2024-06-30 | $0.00 6-K · filed 2024-09-16 | |
| 2023-12-31 | $6.92M 20-F · filed 2026-03-26 | |
| 2023-06-30 | $6.92M 6-K · filed 2024-09-16 | |
| 2022-12-31 | $12.36M 20-F · filed 2025-03-27 | |
| 2022-06-30 | $12.15M 6-K · filed 2023-09-13 | |
| 2021-12-31 | $4.39M 20-F · filed 2024-03-28 | |
| 2021-06-30 | $406.00K 6-K · filed 2022-09-07 | |
| 2020-12-31 | $2.10M 20-F · filed 2023-03-30 | |
| 2020-06-30 | $2.10M 6-K · filed 2021-08-31 | |
| 2019-12-31 | $27.08M 20-F · filed 2022-03-31 | |
| 2019-06-30 | $19.99M 6-K · filed 2020-09-15 | |
| 2018-12-31 | $63.64M 20-F · filed 2021-04-02 | |
| 2017-12-31 | $22.74M 20-F · filed 2020-04-27 | |
| 2016-12-31 | $23.93M 20-F · filed 2019-04-29 | |
| 2015-12-31 | $38.16M 20-F · filed 2018-03-30 |